<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">systhiper</journal-id><journal-title-group><journal-title xml:lang="ru">Системные гипертензии</journal-title><trans-title-group xml:lang="en"><trans-title>Systemic Hypertension</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2075-082X</issn><issn pub-type="epub">2542-2189</issn><publisher><publisher-name>LLC «ИнтерМедсервис»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.38109/2075-082X-2026-1-5-8</article-id><article-id custom-type="elpub" pub-id-type="custom">systhiper-868</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>СОВЕТ ЭКСПЕРТОВ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>COUNCIL OF EXPERTS</subject></subj-group></article-categories><title-group><article-title>Роль нарушения регуляции альдостерона в отсутствии контроля АД и новые терапевтические стратегии в лечении резистентной АГ. Резолюция совета экспертов</article-title><trans-title-group xml:lang="en"><trans-title>Role of aldosterone dysregulation in uncontrolled blood pressure and new therapeutic strategies in resistant arterial hypertension. Expert council resolution</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9822-4357</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чазова</surname><given-names>И. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Chazova</surname><given-names>Irina E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чазова Ирина Евгеньевна, академик РАН, профессор, д.м.н., заместитель генерального директора по научно-экспертной работе, руководитель отдела гипертонии, Институт клинической кардиологии им. А.Л. Мясникова, </p><p>ул. Академика Чазова, д. 15 а, г. Москва, 121552.</p></bio><bio xml:lang="en"><p>Irina E. Chazova, Dr. of Sci. (Med.), Professor, Acad. of RAS, Chief of the Hypertension Department, A.L. Myasnikov Research Institute of Cardiology,</p><p>15a, Academician Chazov St., Moscow, 121552.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5873-1768</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кобалава</surname><given-names>Ж. Д.</given-names></name><name name-style="western" xml:lang="en"><surname>Kobalava</surname><given-names>Zhanna D.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кобалава Жанна Давидовна, член-корр. РАН, д.м.н., профессор, д.м.н., профессор, заведующая кафедрой внутренних болезней с курсом кардиологии и функциональной диагностики им. акад. В. С. Моисеева, Медицинский институт, </p><p> д. 6, ул. Миклухо-Маклая, г. Москва,117198. </p></bio><bio xml:lang="en"><p>Zhanna D. Kobalava, Dr. of Sci. (Med.), Professor, Corresponding Member of RAS, Head of the Department of Internal Diseases with Cardiology and functional Diagnostics Course named after Academician V. S. Moiseev,</p><p>6, Miklukho-Maklaya St., Moscow, 117198.</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0758-5609</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Подзолков</surname><given-names>В. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Podzolkov</surname><given-names>Valery I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Подзолков Валерий Иванович, д.м.н., профессор, заведующий кафедрой факультетской терапии № 2, Институт клинической медицины им. Н.В. Склифосовского, директор факультетской терапевтической клиники УКБ №4, </p><p>ул. Трубецкая, д. 8, стр. 2, г. Москва, 119048.</p></bio><bio xml:lang="en"><p>Valery I. Podzolkov, Dr. of Sci. (Med.), professor, Head of Department of Faculty Therapy No 2, N.V. Sklifosovsky Institute of Clinical Medicine,</p><p>8/2, Trubetskaya St., Moscow, 119048.</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2699-1610</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Брагина</surname><given-names>А. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Bragina</surname><given-names>Anna E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Брагина Анна Евгеньевна, д.м.н., профессор кафедры факультетской терапии №2, Институт клинической медицины им. Н.В. Склифосовского, </p><p>ул. Трубецкая, д. 8, стр. 2, г. Москва, 119048.</p></bio><bio xml:lang="en"><p>Anna E. Bragina, Dr. of Sci. (Med.), Professor, Professor of the Department of Faculty Therapy No 2, N.V. Sklifosovsky Institute of Clinical Medicine, </p><p>8/2, Trubetskaya St., Moscow, 119048.</p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2028-8748</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кисляк</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kislyak</surname><given-names>Oxana A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кисляк Оксана Андреевна, д.м.н., профессор, профессор кафедры факультетской терапии, Институт клинической медицины, </p><p>ул. Островитянова, д. 1, г. Москва, 117997.</p></bio><bio xml:lang="en"><p>Oxana A. Kislyak, Dr. of Sci. (Med.), Professor, Professor of the Department of Faculty Therapy, Institute of Clinical Medicine, </p><p>1, Ostrovityanova St., Moscow, 117997.</p></bio><xref ref-type="aff" rid="aff-4"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9853-9087</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Данилов</surname><given-names>Н. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Danilov</surname><given-names>Nikolay M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Данилов Николай Михайлович, д.м.н., ведущий научный сотрудник, отдел гипертонии, Институт клинической кардиологии имени А.Л. Мясникова,</p><p>ул. Академика Чазова, д. 15 а, г. Москва, 121552.</p></bio><bio xml:lang="en"><p>Nikolay M. Danilov, Dr. of Sci. (Med.), Leading Research of Hypertension Department, A.L. Myasnikov Scientific Research Institute of Clinical Cardiology, </p><p>15a, Academician Chazov St., Moscow, 121552.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0060-095X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сивакова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Sivakova</surname><given-names>Olga A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сивакова Ольга Анатольевна, к.м.н., заведующая 5 кардиологическим отделением, Институт клинической кардиологии имени А.Л. Мясникова,</p><p>ул. Академика Чазова, д. 15 а, г. Москва, 121552.</p></bio><bio xml:lang="en"><p>Olga A. Sivakova, Cand. of Sci. (Med.), Head of the 5th Cardiology Department, A.L. Myasnikov Scientific Research Institute of Clinical Cardiology, </p><p>15a, Academician Chazov St., Moscow, 121552.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5215-4894</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Блинова</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Blinova</surname><given-names>Nataliya V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Блинова Наталия Владимировна, к.м.н., старший научный сотрудник, отдел гипертонии, Институт клинической кардиологии им. А.Л. Мясникова, </p><p>ул. Академика Чазова, д. 15 а, г. Москва, 121552.</p></bio><bio xml:lang="en"><p>Nataliya V. Blinova, Cand. of Sci. (Med.), Senior Researcher, Department of Hypertension, A.L. Myasnikov Institute of Clinical Cardiology, </p><p>15a, Academician Chazov St., Moscow, 121552.</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр кардиологии имени академика Е.И. Чазова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>E.I. Chazov National Medical Research Center of Cardiology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГАОУ ВО «Российский университет дружбы народов имени Патриса Лумумбы»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Peoples’ Friendship University of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>I.M. Sechenov First Moscow State Medical University (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>ФГАОУ ВО «Российский национальный исследовательский медицинский университет им. Н.И. Пирогова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pirogov Russian Federation National Research Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>01</day><month>04</month><year>2026</year></pub-date><volume>23</volume><issue>1</issue><fpage>5</fpage><lpage>8</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Чазова И.Е., Кобалава Ж.Д., Подзолков В.И., Брагина А.Е., Кисляк О.А., Данилов Н.М., Сивакова О.А., Блинова Н.В., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Чазова И.Е., Кобалава Ж.Д., Подзолков В.И., Брагина А.Е., Кисляк О.А., Данилов Н.М., Сивакова О.А., Блинова Н.В.</copyright-holder><copyright-holder xml:lang="en">Chazova I.E., Kobalava Z.D., Podzolkov V.I., Bragina A.E., Kislyak O.A., Danilov N.M., Sivakova O.A., Blinova N.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.syst-hypertension.ru/jour/article/view/868">https://www.syst-hypertension.ru/jour/article/view/868</self-uri><abstract><p>В конце апреля 2025 года прошло совещание экспертов, посвященное обсуждению возможных причин недостижения контроля АД, роли нарушения регуляции альдостерона в патогенезе неконтролируемой и резистентной АГ, а также будущих терапевтических опций, направленных на данное патогенетическое звено, а именно класса ингибиторов альдостеронсинтазы.</p></abstract><trans-abstract xml:lang="en"><p>At the end of April 2025 an expert council meeting was held, devoted to the discussion of the uncontrolled blood pressure, role of aldosterone dysregulation in pathogenesis of uncontrolled and resistant hypertension, and new therapeutic options targeting aldosterone- aldosterone synthase inhibitors. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>резистентная артериальная гипертензия</kwd><kwd>альдостерон</kwd><kwd>ингибиторы альдостеронсинтазы</kwd><kwd>артериальное давление</kwd></kwd-group><kwd-group xml:lang="en"><kwd>resistant hypertension</kwd><kwd>aldosterone</kwd><kwd>blood pressure</kwd><kwd>aldosterone synthase inhibitors</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">. Global report on hypertension 2025: high stakes – turning evidence into action. Geneva: World Health Organization; 2025. Licence: CC BY-NC-SA 3.0 IGO.</mixed-citation><mixed-citation xml:lang="en">Global report on hypertension 2025: high stakes – turning evidence into action. Geneva: World Health Organization; 2025. Licence: CC BY-NC-SA 3.0 IGO.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021 Sep 11;398(10304):957-980. https://doi.org/10.1016/s0140-6736(21)01330-1</mixed-citation><mixed-citation xml:lang="en">NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021 Sep 11;398(10304):957-980. https://doi.org/10.1016/s0140-6736(21)01330-1</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Аксенова А.В., Ощепкова Е.В., Горбунова Е.В., Макаров С.А., Аксенов Н.Н., Мусаева Н.З., Чазова И.Е. Контролируемая и неконтролируемая артериальная гипертония: особенности моно- и комбинированной ангигипертензивной терапии (по данным национального регистра артериальной гипертонии, 2019-2022 гг.). Системные гипертензии. 2024;21(2):19-26. https://doi.org/10.38109/2075-082X-2024-2-17-24.</mixed-citation><mixed-citation xml:lang="en">Aksenova A.V., Oshchepkova E.V., Gorbunova E.V., Makarov S.A., Aksenov N.N., Musaeva N.Z., Chazova I.E. Controlled and uncontrolled arterial hypertension: features of mono- and combined antihypertensive therapy (according to the national registry of arterial hypertension, 2019-2022). Systemic Hypertension. 2024;21(2):19-26. (In Russ.) https://doi.org/10.38109/2075-082X-2024-2-17-24</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Аксенова А.В., Сивакова О.А., Блинова Н.В., Данилов Н.М., Елфимова Е.М., Кисляк О.А., Литвин А.Ю., Ощепкова Е.В., Фомин В.В., Чихладзе Н.М., Щелкова Г.В., Чазова И.Е. Консенсус экспертов Российского медицинского общества по артериальной гипертонии по диагностике и лечению резистентной артериальной гипертонии. Терапевтический архив. 2021;93(9):1018-1029. https://doi.org/10.26442/00403660.2021.09.201007</mixed-citation><mixed-citation xml:lang="en">Aksenova AV, Sivakova OA, Blinova NV, Danilov NM, Elfimova EM, Kisliak OA, Litvin AYu, Oshchepkova EV, Fomin VV, Chikhladze NM, Shelkova GV, Chazova IE. Russian Medical Society for Arterial Hypertension expert consensus. Resistant hypertension: detection and management. Terapevticheskii Arkhiv (Ter. Arkh). 2021;93(9):1018-1029. https://doi.org/10.26442/00403660.2021.09.201007</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ebinger J.E., Kauko A., FinnGen, Bello N.A., Cheng S., Niiranen T. Apparent treatment-resistant hypertension associated lifetime cardiovascular risk in a longitudinal national registry. European Journal of Preventive Cardiology. 2023;30(10):960-968. https://doi.org/10.1093/eurjpc/zwad066</mixed-citation><mixed-citation xml:lang="en">Ebinger J.E., Kauko A., FinnGen, Bello N.A., Cheng S., Niiranen T. Apparent treatment-resistant hypertension associated lifetime cardiovascular risk in a longitudinal national registry. European Journal of Preventive Cardiology. 2023;30(10):960-968. https://doi.org/10.1093/eurjpc/zwad066</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Чазова И.Е., Чихладзе Н.М., Блинова Н.В., Аксенова А.В., Алексеева Т.А., Амбатьелло Л.Г., Баланова Ю.А., Брагина А.Е., Данилов Н.М., Драпкина О.М., Дроздова Л.Ю., Ежов М.В., Елфимова Е.М., Жернакова Ю.В., Жиров И.В., Кисляк О.А., Литвин А.Ю., Небиеридзе Д.В., Остроумова О.Д., Подзолков В.И., Сергиенко И.В., Сивакова О.А., Стародубова А.В., Стрюк Р.И., Терещенко С.Н., Трушина О.Ю., Щелкова Г.В. Клинические рекомендации Российского медицинского общества по артериальной гипертонии (РМОАГ) и Евразийской Ассоциации Кардиологов (ЕАК) по диагностике и лечению артериальной гипертонии (2024). Системные гипертензии. 2024;21(4):5-110. https://doi.org/10.38109/2075-082X-2024-4-5-109</mixed-citation><mixed-citation xml:lang="en">Chazova I.E., Chikhladze N.M., Blinova N.V., Aksenova A.V., Alekseeva T.A., Ambatiello L.G., Balanova Yu.A., Bragina A.E., Danilov N.M., Drapkina O.M., Drozdova L.Yu., Ezhov M.V., Elfimova E.M., Zhernakova Yu.V., Zhirov I.V., Kislyak O.A., Litvin A.Yu., Nebieridze D.V., Ostroumova O.D., Podzolkov V.I., Sergienko I.V., Sivakova O.A., Starodubova A.V., Stryuk R.I., Tereshchenko S.N., Trushina O.Yu., Shchelkova G.V. Clinical guidelines of the Russian Medical Society on arterial Hypertension (RSH) and the Eurasian association of Cardiologists (EaC) for the diagnosis and treatment of arterial hypertension (2024). Systemic Hypertension. 2024;21(4):5-110. (In Russ.) https://doi.org/10.38109/2075-082X-2024-4-5-109</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Tian Z., Barbosa C.V., Lang H., Bauersachs J., Melk A., Schmidt B.M.W. Efficacy of pharmacological and interventional treatment for resistant hypertension: a network meta-analysis. Cardiovasc Res. 2024 Feb 27;120(1):108-119. https://doi.org/10.1093/cvr/cvad165</mixed-citation><mixed-citation xml:lang="en">Tian Z., Barbosa C.V., Lang H., Bauersachs J., Melk A., Schmidt B.M.W. Efficacy of pharmacological and interventional treatment for resistant hypertension: a network meta-analysis. Cardiovasc Res. 2024 Feb 27;120(1):108-119. https://doi.org/10.1093/cvr/cvad165</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Hargovan M, Ferro A, Aldosterone synthase inhibitors in hypertension: current status and future possibilities. JRSM Cardiovasc Dis. 2014;3:1-9. https://doi.org/10.1177/2048004014522440</mixed-citation><mixed-citation xml:lang="en">Hargovan M, Ferro A, Aldosterone synthase inhibitors in hypertension: current status and future possibilities. JRSM Cardiovasc Dis. 2014;3:1-9. https://doi.org/10.1177/2048004014522440</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Leopold JA, Ingelfinger JR. Aldosterone and treatment-resistant hypertension. N Engl J Med. 2023;388(5):464-467. https://doi.org/10.1056/NEJMe2213559</mixed-citation><mixed-citation xml:lang="en">Leopold JA, Ingelfinger JR. Aldosterone and treatment-resistant hypertension. N Engl J Med. 2023;388(5):464-467. https://doi.org/10.1056/NEJMe2213559</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Verhovez A, Williams TA, Monticone S, et al. Genomic and non-genomic effects of aldosterone. Curr Signal Transduct Ther. 2012;7(2):132-141. http://doi.org/10.2174/157436212800376708</mixed-citation><mixed-citation xml:lang="en">Verhovez A, Williams TA, Monticone S, et al. Genomic and non-genomic effects of aldosterone. Curr Signal Transduct Ther. 2012;7(2):132-141. http://doi.org/10.2174/157436212800376708</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Brown JM, Siddiqui M, Calhoun DA, et al. The unrecognized prevalence of primary aldosteronism: a crosssectional study. Ann Intern Med. 2020;173(1):10-20. https://doi.org/10.7326/M20-0065</mixed-citation><mixed-citation xml:lang="en">Brown JM, Siddiqui M, Calhoun DA, et al. The unrecognized prevalence of primary aldosteronism: a crosssectional study. Ann Intern Med. 2020;173(1):10-20. https://doi.org/10.7326/M20-0065</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Yuan YE, Haas AV, Rosner B, et al. Elevated blood pressure and aldosterone dysregulation in young black women versus white women on controlled sodium diets. J Clin Endocrinol Metab. 2024;109(2):e773-e779. https://doi.org/10.1210/clinem/dgad512</mixed-citation><mixed-citation xml:lang="en">Yuan YE, Haas AV, Rosner B, et al. Elevated blood pressure and aldosterone dysregulation in young black women versus white women on controlled sodium diets. J Clin Endocrinol Metab. 2024;109(2):e773-e779. https://doi.org/10.1210/clinem/dgad512</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Papadopoulou-Marketou N, Vaidya A, Dluhy R, et al. Hyperaldosteronism. In: Feingold KR, Anawalt B, Blackman MR, et al, eds. Endotext [Internet]. MDText.com, Inc.; Aug 6, 2020. https://www.ncbi.nlm.nih.gov/books/NBK279065/</mixed-citation><mixed-citation xml:lang="en">Papadopoulou-Marketou N, Vaidya A, Dluhy R, et al. Hyperaldosteronism. In: Feingold KR, Anawalt B, Blackman MR, et al, eds. Endotext [Internet]. MDText.com, Inc.; Aug 6, 2020. https://www.ncbi.nlm.nih.gov/books/NBK279065/</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Inoue K, Goldwater D, Allison M, et al. Serum aldosterone concentration, blood pressure, and coronary artery calcium: the multi-ethnic study of atherosclerosis [article and online supplement]. Hypertension. 2020;76(1):113-120. https://doi.org/10.1161/hypertensionaha.120.15006</mixed-citation><mixed-citation xml:lang="en">Inoue K, Goldwater D, Allison M, et al. Serum aldosterone concentration, blood pressure, and coronary artery calcium: the multi-ethnic study of atherosclerosis [article and online supplement]. Hypertension. 2020;76(1):113-120. https://doi.org/10.1161/hypertensionaha.120.15006</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Crompton M, Skinner LJ, Satchell SC, et al. Aldosterone: essential for life but damaging to the vascular endothelium. Biomolecules. 2023;13(6):1004. https://doi.org/10.3390/biom13061004</mixed-citation><mixed-citation xml:lang="en">Crompton M, Skinner LJ, Satchell SC, et al. Aldosterone: essential for life but damaging to the vascular endothelium. Biomolecules. 2023;13(6):1004. https://doi.org/10.3390/biom13061004</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Bogman K., Schwab D., Delporte M-L. et al. Preclinical and Early Clinical Profile of a Highly Selective and Potent Oral Inhibitor of Aldosterone Synthase (CYP11B2). Hypertension. 2017;69(1):189-196. https://doi.org/10.1161/HYPERTENSIONAHA.116.07716</mixed-citation><mixed-citation xml:lang="en">Bogman K., Schwab D., Delporte M-L. et al. Preclinical and Early Clinical Profile of a Highly Selective and Potent Oral Inhibitor of Aldosterone Synthase (CYP11B2). Hypertension. 2017;69(1):189-196. https://doi.org/10.1161/HYPERTENSIONAHA.116.07716</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Freeman M.W., Halvorsen Y-D., Marshall W. et al. Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension. N Engl J Med. 2023;388(5):395-405. https://doi.org/10.1056/NEJMoa2213169</mixed-citation><mixed-citation xml:lang="en">Freeman M.W., Halvorsen Y-D., Marshall W. et al. Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension. N Engl J Med. 2023;388(5):395-405. https://doi.org/10.1056/NEJMoa2213169</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Flack J.M., Azizi M., Brown J.M. et al. Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension. N Engl J Med 2025;393:1363-1374. https://doi.org/10.1056/nejmoa2507109</mixed-citation><mixed-citation xml:lang="en">Flack J.M., Azizi M., Brown J.M. et al. Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension. N Engl J Med 2025;393:1363-1374. https://doi.org/10.1056/nejmoa2507109</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">A Study to Investigate the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants With Resistant Hypertension (Bax24) https://clinicaltrials.gov/study/NCT06168409?term=%20NCT06168409%20&amp;rank=1</mixed-citation><mixed-citation xml:lang="en">A Study to Investigate the Effect of Baxdrostat on Ambulatory Blood Pressure in Participants With Resistant Hypertension (Bax24) https://clinicaltrials.gov/study/NCT06168409?term=%20NCT06168409%20&amp;rank=1</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
